Dallah Healthcare’s board of directors has decided to cancel a recommendation to increase the company’s capital as part of the acquisition process of Bagedo & Dr. Erfan General Hospital Co.
Last November, company’s board had recommended a capital increase through the issuance of 7.47 million share worth a nominal value of SAR 74.7 million as part of a deal to acquire Bagedo & Dr. Erfan General Hospital Co. The company has since axed its plans to acquire the hospital.
Comments Analysis: